These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9752063)

  • 1. [The recommended daily intake of folic acid is insufficient for optimum homocysteine level].
    Willems HP; Den Heijer M; Gerrits WB; Bos GM
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1473-4. PubMed ID: 9752063
    [No Abstract]   [Full Text] [Related]  

  • 2. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R; Collins R
    J Cardiovasc Risk; 1998 Aug; 5(4):249-55. PubMed ID: 9919473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nutritional medicine 2007].
    Hauner H
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1411-3. PubMed ID: 17570092
    [No Abstract]   [Full Text] [Related]  

  • 4. [The recommended daily amount of folic acid is insufficient for optimum homocysteine levels].
    Brouwer IA; Van Dusseldorp M; De Vries JH; Steegers-Theunissen RP
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1473. PubMed ID: 9752062
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering plasma homocysteine.
    Med Lett Drugs Ther; 2003 Oct; 45(1168):85-6. PubMed ID: 14576622
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
    Righetti M; Ferrario GM; Milani S; Serbelloni P; La Rosa L; Uccellini M; Sessa A
    Med Sci Monit; 2003 Apr; 9(4):PI19-24. PubMed ID: 12709680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Homocysteine--risk factor or risk indicator?].
    Rafflenbeul W
    MMW Fortschr Med; 2005 Nov; 147(44):28-30. PubMed ID: 16302487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
    Kang HG; Lee BS; Hahn H; Lee JH; Ha IS; Cheong HI; Choi Y
    Pediatr Nephrol; 2002 Jul; 17(7):511-4. PubMed ID: 12172764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease.
    Liu CS; Chiang HC; Chen HW
    Nutrition; 2004; 20(11-12):974-8. PubMed ID: 15561486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma homocysteine concentration and its relationship with the development of preeclampsia. Effect of prenatal administration of folic acid].
    Fernández M; Fernández G; Diez-Ewald M; Torres E; Vizcaíno G; Fernández N; Narváez J; Arteaga-Vizcaíno M
    Invest Clin; 2005 Jun; 46(2):187-95. PubMed ID: 16001750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients.
    Lim HJ; Choi YM; Choue R
    Nutr Res; 2008 Nov; 28(11):767-74. PubMed ID: 19083486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G1793A polymorphisms in the methylene-tetrahydrofolate gene: effect of folic acid on homocysteine levels.
    Melo SS; Persuhn DC; Meirelles MS; Jordao AA; Vannucchi H
    Mol Nutr Food Res; 2006 Aug; 50(8):769-74. PubMed ID: 16865747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine, folic acid, B vitamins and cardiovascular risk.
    Blacher J; Safar ME
    J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
    Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
    Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
    Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.